CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
-1.39%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$345M
AUM Growth
+$21M
(+6.5%)
Cap. Flow
+$33M
Cap. Flow
% of AUM
9.58%
Top 10 Holdings %
Top 10 Hldgs %
32.78%
Holding
466
New
14
Increased
365
Reduced
39
Closed
20
Top Buys
| 1 |
Amazon
AMZN
|
$3.98M |
| 2 |
Procter & Gamble
PG
|
$3.03M |
| 3 |
Booking.com
BKNG
|
$2.86M |
| 4 |
Apple
AAPL
|
$2.77M |
| 5 |
SPDR Gold MiniShares Trust
GLDM
|
$2.63M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$3.25M |
| 2 |
TSMC
TSM
|
$3.11M |
| 3 |
Carnival Corp
CCL
|
$2.64M |
| 4 |
On Holding
ONON
|
$2.57M |
| 5 |
Advanced Micro Devices
AMD
|
$2.07M |
Sector Composition
| 1 | Technology | 38.24% |
| 2 | Consumer Discretionary | 20.57% |
| 3 | Healthcare | 19.52% |
| 4 | Communication Services | 8.19% |
| 5 | Consumer Staples | 3.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Zentalis Pharmaceuticals
ZNTL
$126M
| $36.3K | 0.01% |
1,809
+1,030
| +132% | +$20.7K |
|
252
Agios Pharmaceuticals
AGIO
$2.09B
| $35.4K | 0.01% |
1,429
+700
| +96% | +$17.3K |
|
253
Merus
MRUS
$5.1B
| $34.8K | 0.01% |
1,477
+867
| +142% | +$20.4K |
|
254
BioCryst Pharmaceuticals
BCRX
$1.74B
| $34.4K | 0.01% |
4,865
+2,388
| +96% | +$16.9K |
|
255
AbCellera Biologics
ABCL
$1.26B
| $34.1K | 0.01% |
7,423
+3,638
| +96% | +$16.7K |
|
256
Maravai LifeSciences
MRVI
$363M
| $33.9K | 0.01% |
3,391
+1,662
| +96% | +$16.6K |
|
257
Myriad Genetics
MYGN
$615M
| $33.7K | 0.01% |
2,101
+1,032
| +97% | +$16.6K |
|
258
Summit Therapeutics
SMMT
$19.3B
| $33.5K | 0.01% |
17,903
+8,758
| +96% | +$16.4K |
|
259
Rhythm Pharmaceuticals
RYTM
$6.78B
| $33.4K | 0.01% |
1,458
+713
| +96% | +$16.3K |
|
260
Zai Lab
ZLAB
$3.42B
| $33.3K | 0.01% |
1,371
+557
| +68% | +$13.5K |
|
261
Vir Biotechnology
VIR
$732M
| $32.3K | 0.01% |
3,448
+1,692
| +96% | +$15.9K |
|
262
Amylyx Pharmaceuticals
AMLX
$910M
| $31.7K | 0.01% |
1,730
+850
| +97% | +$15.6K |
|
|
SAGE
263
DELISTED
Sage Therapeutics
SAGE
| $31.5K | 0.01% |
1,531
+748
| +96% | +$15.4K |
|
264
Xencor
XNCR
$610M
| $31.2K | 0.01% |
1,548
+756
| +95% | +$15.2K |
|
265
Mirum Pharmaceuticals
MIRM
$3.82B
| $31.2K | 0.01% |
986
+488
| +98% | +$15.4K |
|
266
Unity
U
$18.5B
| $30.2K | 0.01% |
961
-8,229
| -90% | -$258K |
|
267
89bio
ETNB
$1.32B
| $30K | 0.01% |
1,945
+990
| +104% | +$15.3K |
|
268
ANI Pharmaceuticals
ANIP
$2.07B
| $29.8K | 0.01% |
513
+248
| +94% | +$14.4K |
|
269
Twist Bioscience
TWST
$1.55B
| $29.8K | 0.01% |
1,470
+721
| +96% | +$14.6K |
|
270
Iovance Biotherapeutics
IOVA
$901M
| $28.9K | 0.01% |
6,356
+3,414
| +116% | +$15.5K |
|
271
Grifois
GRFS
$6.89B
| $28.6K | 0.01% |
3,132
+1,618
| +107% | +$14.8K |
|
272
Aurinia Pharmaceuticals
AUPH
$1.63B
| $28.5K | 0.01% |
3,673
+1,798
| +96% | +$14K |
|
273
MannKind Corp
MNKD
$1.7B
| $28.5K | 0.01% |
6,892
+3,428
| +99% | +$14.2K |
|
274
Geron
GERN
$893M
| $28.5K | 0.01% |
13,426
+6,757
| +101% | +$14.3K |
|
|
MORF
275
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $28.4K | 0.01% |
1,238
+638
| +106% | +$14.6K |
|